If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) was previously published as Current Drug Targets-CNS & Neurological Disorders.

Publisher: Bentham Science Publishers

Related content
Volume 9, Number 4, August 2010

< previous issue | all issues | next issue >

Articles

Favourites:Add to Favourites

Free Content Commentary
pp. 383-383(1)
Author: Hirth, Frank

Favourites:Add to Favourites

Transgenic Mouse Models of Tauopathy in Drug Discovery
pp. 403-428(26)
Authors: Noble, W.; Hanger, D.P.; Gallo, J.-M.

Favourites:Add to Favourites

Insights from Mouse Models to Understand Neurodegeneration in Down Syndrome
pp. 429-438(10)
Authors: Fillat, Cristina; Dierssen, Mara; Martinez de Lagran, Maria; Altafaj, Xavier

Favourites:Add to Favourites

Oxidative Stress and Altered Mitochondrial Function in Neurodegenerative Diseases: Lessons From Mouse Models
pp. 439-454(16)
Authors: Fernandez-Checa, J.C.; Fernandez, A.; Morales, A.; Mari, M.; Garcia-Ruiz, C.; Colell, A.

Favourites:Add to Favourites

Transgenic Mouse Models of Parkinson's Disease and Huntington's Disease
pp. 455-470(16)
Authors: D. Skaper, Stephen; Giusti, Pietro

Favourites:Add to Favourites

The Role of Phosphorylation in Synucleinopathies: Focus on Parkinson's Disease
pp. 471-481(11)
Authors: Cavallarin, Nadia; Vicario, Mattia; Negro, Alessandro

Favourites:Add to Favourites

α-Synuclein- and MPTP-Generated Rodent Models of Parkinson's Disease and the Study of Extracellular Striatal Dopamine Dynamics: A Microdialysis Approach
pp. 482-490(9)
Authors: Bazzu, Gianfranco; Calia, Giammario; Puggioni, Giulia; Spissu, Ylenia; Rocchitta, Gaia; Debetto, Patrizia; Grigoletto, Jessica; Zusso, Morena; Migheli, Rossana; Andrea Serra, Pier; Speranza Desole, Maria; Miele, Egidio

Favourites:Add to Favourites

Unraveling the Complexity of Amyotrophic Lateral Sclerosis: Recent Advances from the Transgenic Mutant SOD1 Mice
pp. 491-503(13)
Authors: Peviani, M.; Caron, I.; Pizzasegola, C.; Gensano, F.; Tortarolo, M.; Bendotti, C.

Favourites:Add to Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more